InMed and the laboratory of Dr. Vikramaditya Yadav at the University of British Columbia collaborate on a proprietary biosynthesis technology to produce bioidentical, high purity, high grade cannabinoids. The host selected is E.coli. In this video, Dr. Yadav talks how an E.coli-based system is uniquely suited for producing cannabinoids.
Why explore cannabinoids as potential therapeutic targets for neurodegenerative diseases?
In this video, Eric A. Adams explains how the body’s endocannabinoid system has natural cannabinoid receptors throughout the body that interact with cannabinoids and are
February 1, 2023
